EIF4A1 and breast carcinoma: Modelska et al. reported that eIF4A1 upregulation is associated with a higher histological grade in estrogen receptor-negative breast cancer tumors, and the combination of eIF4A1 with eIF4B and eIF4E might serve as an independent predictor of prognosis in patients with breast cancer (Modelska et al., 2015b).